-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Key features of the EXPANSE clinical program for apixaban in the prevention and treatment of thrombotic disorders
Nadia Rosencher, Paul Zufferey, Silvy Laporte, Patrick Mismetti
Review Article: Clinical Investigation
-
Key features of the EXPANSE clinical program for apixaban in the prevention and treatment of thrombotic disorders
Nadia Rosencher, Paul Zufferey, Silvy Laporte, Patrick Mismetti
Review Article: Clinical Investigation
-
Key features of the EXPANSE clinical program for apixaban in the prevention and treatment of thrombotic disorders
Nadia Rosencher, Paul Zufferey, Silvy Laporte, Patrick Mismetti
Review Article: Clinical Investigation
-
Key features of the EXPANSE clinical program for apixaban in the prevention and treatment of thrombotic disorders
Nadia Rosencher, Paul Zufferey, Silvy Laporte, Patrick Mismetti
Review Article: Clinical Investigation
-
Key features of the EXPANSE clinical program for apixaban in the prevention and treatment of thrombotic disorders
Nadia Rosencher, Paul Zufferey, Silvy Laporte, Patrick Mismetti
Review Article: Clinical Investigation
-
Key features of the EXPANSE clinical program for apixaban in the prevention and treatment of thrombotic disorders
Nadia Rosencher, Paul Zufferey, Silvy Laporte, Patrick Mismetti
Review Article: Clinical Investigation
-
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Alessandro Marinelli, Iacopo Ciccarelli, Alessandro Capucci
Review Article: Clinical Investigation
-
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Alessandro Marinelli, Iacopo Ciccarelli, Alessandro Capucci
Review Article: Clinical Investigation
-
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Alessandro Marinelli, Iacopo Ciccarelli, Alessandro Capucci
Review Article: Clinical Investigation
-
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Alessandro Marinelli, Iacopo Ciccarelli, Alessandro Capucci
Review Article: Clinical Investigation
-
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Alessandro Marinelli, Iacopo Ciccarelli, Alessandro Capucci
Review Article: Clinical Investigation
-
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Alessandro Marinelli, Iacopo Ciccarelli, Alessandro Capucci
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation